Rabourn Amy Zaremba

Insider Reports History

Location
Farmington Hills, MI
Signature
/s/ Amy Rabourn
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rabourn Amy Zaremba:

Company Role Class Num Shares Value Price $ Report Date Ownership
Opus Genetics, Inc. Head of Fin. Quality Assurance Common Stock 193,128 $388,187 $2.01 22 Jan 2026 Direct
Opus Genetics, Inc. Head of Fin. Quality Assurance Employee Stock Option (right to buy) 39,500 13 Mar 2025 Direct

Insider Reports Filed by Rabourn Amy Zaremba

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IRD Opus Genetics, Inc. 22 Jan 2026 1 $0 4 Head of Fin. Quality Assurance 26 Jan 2026, 19:49
IRD Opus Genetics, Inc. 18 Jan 2026 1 -$7,119 4 Head of Fin. Quality Assurance 21 Jan 2026, 16:05
IRD Opus Genetics, Inc. 10 Jan 2026 1 -$7,624 4 Head of Fin. Quality Assurance 13 Jan 2026, 17:21
IRD Opus Genetics, Inc. 13 Mar 2025 2 $0 4 SVP of Finance 17 Mar 2025, 20:54
IRD Opus Genetics, Inc. 04 Feb 2025 1 -$9,337 4 SVP of Finance 06 Feb 2025, 16:37
IRD Ocuphire Pharma, Inc. 18 Jan 2024 2 $0 4 SVP of Finance 22 Jan 2024, 18:01
IRD Ocuphire Pharma, Inc. 10 Jan 2024 1 -$12,897 4 SVP of Finance 12 Jan 2024, 16:17
IRD Ocuphire Pharma, Inc. 10 Jan 2023 2 $0 4 SVP of Finance 12 Jan 2023, 16:30
IRD Ocuphire Pharma, Inc. 28 Jan 2022 1 $0 4 VP of Finance 01 Feb 2022, 15:23